Guorong Zou

805 total citations
30 papers, 391 citations indexed

About

Guorong Zou is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Guorong Zou has authored 30 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Otorhinolaryngology, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in Guorong Zou's work include Head and Neck Cancer Studies (13 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Guorong Zou is often cited by papers focused on Head and Neck Cancer Studies (13 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Guorong Zou collaborates with scholars based in China. Guorong Zou's co-authors include Xiaolong Cao, Chunyan Lan, Yin Wang, Xin Huang, Xianbi Li, Jundong Li, Mian He, Jiayu Ling, Haowen Yan and Xinping Cao and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Guorong Zou

27 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guorong Zou China	11	172	105	98	83	58	30	391
Sunil Saini India	10	110 0.6×	96 0.9×	42 0.4×	31 0.4×	31 0.5×	39	335
Yuhei Miyasaka Japan	11	72 0.4×	160 1.5×	53 0.5×	16 0.2×	69 1.2×	46	366
Haoping Xu China	13	79 0.5×	65 0.6×	107 1.1×	6 0.1×	35 0.6×	39	428
Pencilla Lang Canada	12	44 0.3×	99 0.9×	108 1.1×	87 1.0×	7 0.1×	50	364
Zhuozhi Chen China	13	56 0.3×	99 0.9×	64 0.7×	46 0.6×	4 0.1×	23	469
Ru Xiang China	7	144 0.8×	40 0.4×	30 0.3×	8 0.1×	21 0.4×	12	337
Dian Ouyang China	10	113 0.7×	41 0.4×	85 0.9×	117 1.4×	11 0.2×	19	358
Francesco Buemi Italy	10	31 0.2×	92 0.9×	25 0.3×	17 0.2×	7 0.1×	17	311
Brandon A. Dyer United States	14	146 0.8×	161 1.5×	93 0.9×	41 0.5×	2 0.0×	45	626
Danhui Huang China	6	201 1.2×	82 0.8×	59 0.6×	8 0.1×	6 0.1×	16	370

Countries citing papers authored by Guorong Zou

Since Specialization

Citations

This map shows the geographic impact of Guorong Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guorong Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guorong Zou more than expected).

Fields of papers citing papers by Guorong Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guorong Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guorong Zou. The network helps show where Guorong Zou may publish in the future.

Co-authorship network of co-authors of Guorong Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Guorong Zou. A scholar is included among the top collaborators of Guorong Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guorong Zou. Guorong Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Silu, Zhanwei Zhuang, Xueting Wu, et al.. (2025). Identification of potential crucial genes and mechanisms associated with metabolically unhealthy obesity based on the gene expression profile. Frontiers in Genetics. 16. 1540721–1540721.

Yang, Yi, et al.. (2024). Platycodon D reduces obesity and non-alcoholic fatty liver disease induced by a high-fat diet through inhibiting intestinal fat absorption. Frontiers in Pharmacology. 15. 1412453–1412453. 4 indexed citations

Ma, Jun, Ying Sun, Ye‐Lin Liang, et al.. (2024). Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial.. Journal of Clinical Oncology. 42(17_suppl). LBA6000–LBA6000. 13 indexed citations

Chen, Yin, Guorong Zou, Yan He, et al.. (2023). Efficiency and toxicity of nab-paclitaxel and camrelizumab in the second or above line treatment of advanced non-small cell lung cancer: a retrospective cohort study. Journal of Thoracic Disease. 15(4). 1838–1847. 10 indexed citations

Li, Juan, Guorong Zou, Wei Wang, et al.. (2023). Treatment options for recurrent platinum-resistant ovarian cancer: A systematic review and Bayesian network meta-analysis based on RCTs. Frontiers in Oncology. 13. 1114484–1114484. 3 indexed citations

Wang, Yin, Jing Zhao, Junxiu Liu, et al.. (2023). Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial. EClinicalMedicine. 65. 102274–102274. 9 indexed citations

Liu, Zhigang, Yuling Zhou, Shuang Yang, et al.. (2021). Olanzapine or dexamethasone, with 5-HT3 receptor antagonist and NK-1 receptor antagonist, to prevent nausea and vomiting induced by cisplatin-based doublet chemotherapy: A non-inferiority, prospective, multi-centered, randomized, controlled, phase III clinical trial.. Journal of Clinical Oncology. 39(15_suppl). TPS12133–TPS12133.

Chen, Xiangchuan, Chaosu Hu, Jixia Li, et al.. (2021). 909P A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy: Updated results. Annals of Oncology. 32. S806–S806. 5 indexed citations

Zou, Guorong, et al.. (2021). Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma: a systematic review and pooled analysis. Journal of Cancer. 12(20). 6209–6215. 2 indexed citations

10.

Ye, Yufeng, Yan He, Guorong Zou, et al.. (2020). Fully-Automated Segmentation of Nasopharyngeal Carcinoma on Dual-Sequence MRI Using Convolutional Neural Networks. Frontiers in Oncology. 10. 166–166. 35 indexed citations

11.

Tan, Meifang, Guorong Zou, Yanling Wei, et al.. (2020). Protein–protein interaction network and potential drug target candidates ofStreptococcus suis. Journal of Applied Microbiology. 131(2). 658–670. 4 indexed citations

12.

Su, Zhen, et al.. (2020). <p>Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era</p>. Therapeutics and Clinical Risk Management. Volume 16. 201–211. 4 indexed citations

13.

Zou, Guorong, et al.. (2020). MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2. Cancer Cell International. 20(1). 85–85. 25 indexed citations

14.

Li, Shengyu, et al.. (2019). Optimization on crucial ejector geometries in a multi-evaporator refrigeration system for tropical region refrigerated trucks. Energy. 189. 116347–116347. 35 indexed citations

15.

Su, Zhen, Guorong Zou, Yan‐Ping Mao, et al.. (2019). Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer. Journal of Cancer. 10(6). 1349–1357. 10 indexed citations

16.

Su, Zhen, Xiaolong Cao, & Guorong Zou. (2019). Brain and frontal‐bone metastasis from nasopharyngeal carcinoma: Case report and literature review. Head & Neck. 41(9). E153–E158. 10 indexed citations

17.

Lin, Liping, Juanjuan Zhao, Guorong Zou, et al.. (2018). Current Smoking has a Detrimental Effect on Survival for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) negative Advanced non-squamous Non-small Cell Lung Cancer (NSCLC) Patients Treated with Pemetrexed Continuation Maintenance. Journal of Cancer. 9(12). 2140–2146. 6 indexed citations

18.

Zou, Guorong, Linyan Guo, & Helin Yang. (2013). A compact tri-band monopole antenna for WLAN and WiMAX applications. International Symposium on Antennas and Propagation. 1. 226–228. 1 indexed citations

19.

Xie, Fang‐Yun, et al.. (2007). [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].. PubMed. 26(8). 880–4. 16 indexed citations

20.

Zou, Guorong, et al.. (2006). Analysis of the prognosis for patients with stage T3N0-1M0 nasopharyngeal carcinoma treated by chemotherapy combined with radiotherapy. Chinese Journal of Clinical Oncology. 3(4). 292–298. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact